Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 249

1.

Influence of HIV Infection on the Natural History of Hepatocellular Carcinoma: Results From a Global Multicohort Study.

Pinato DJ, Allara E, Chen TY, Trevisani F, Minguez B, Zoli M, Harris M, Dalla Pria A, Merchante N, Platt H, Jain M, Caturelli E, Kikuchi L, Pineda J, Nelson M, Farinati F, Rapaccini GL, Aytaman A, Yin M, Tan CK, Bower M, Giannini EG, Bräu N; Liver Cancer in HIV and ITA.LI.CA Study Groups.

J Clin Oncol. 2018 Dec 18:JCO1800885. doi: 10.1200/JCO.18.00885. [Epub ahead of print]

PMID:
30562130
2.

Development and Validation of a Scoring System That Includes Corrected QT Interval For Risk Analysis of Patients With Cirrhosis and Gastrointestinal Bleeding.

Biselli M, Gramenzi A, Lenzi B, Dall'Agata M, Pierro ML, Perricone G, Tonon M, Bellettato L, D'Amico G, Angeli P, Boffelli S, Bonavita ME, Domenicali M, Caraceni P, Bernardi M, Trevisani F.

Clin Gastroenterol Hepatol. 2018 Dec 14. pii: S1542-3565(18)31379-X. doi: 10.1016/j.cgh.2018.12.006. [Epub ahead of print]

PMID:
30557740
3.

Reply.

Vitale A, Farinati F, Borzio M, Trevisani F, Cllo U.

Hepatology. 2019 Jan;69(1):465-466. doi: 10.1002/hep.30322. No abstract available.

PMID:
30376183
4.

Do We Truly Care About the Functional Outcomes for Renal Cancer Patients? Multidisciplinarity Is Still Far Away.

Capitanio U, Larcher A, Kriegmair MC, Bertolo R, Salagierski M, Campi R, Klatte T, Trevisani F, Montorsi F, Mir MC, Ouzaid I; Kidney Cancer Working Group of the Young Academic Urologists Working Party of the European Association of Urology.

Eur Urol. 2018 Sep 17. pii: S0302-2838(18)30642-0. doi: 10.1016/j.eururo.2018.08.040. [Epub ahead of print] No abstract available.

PMID:
30237026
5.

Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical Trial.

Khan KH, Cunningham D, Werner B, Vlachogiannis G, Spiteri I, Heide T, Mateos JF, Vatsiou A, Lampis A, Damavandi MD, Lote H, Huntingford IS, Hedayat S, Chau I, Tunariu N, Mentrasti G, Trevisani F, Rao S, Anandappa G, Watkins D, Starling N, Thomas J, Peckitt C, Khan N, Rugge M, Begum R, Hezelova B, Bryant A, Jones T, Proszek P, Fassan M, Hahne JC, Hubank M, Braconi C, Sottoriva A, Valeri N.

Cancer Discov. 2018 Oct;8(10):1270-1285. doi: 10.1158/2159-8290.CD-17-0891. Epub 2018 Aug 30.

PMID:
30166348
6.

Restaging Patients With Hepatocellular Carcinoma Before Additional Treatment Decisions: A Multicenter Cohort Study.

Vitale A, Farinati F, Noaro G, Burra P, Pawlik TM, Bucci L, Giannini EG, Faggiano C, Ciccarese F, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Borzio F, Sacco R, Cabibbo G, Virdone R, Marra F, Felder M, Morisco F, Benvegnù L, Gasbarrini A, Svegliati-Baroni G, Foschi FG, Olivani A, Masotto A, Nardone G, Colecchia A, Fornari F, Marignani M, Vicari S, Bortolini E, Cozzolongo R, Grasso A, Aliberti C, Bernardi M, Frigo AC, Borzio M, Trevisani F, Cillo U; Italian Liver Cancer (ITA.LI.CA) group.

Hepatology. 2018 Oct;68(4):1232-1244. doi: 10.1002/hep.30185.

PMID:
30048016
7.

Predictive and prognostic effect of inflammatory lymphadenopathies in renal cell carcinoma.

Muttin F, Pecoraro A, Larcher A, Dell'Oglio P, Nini A, Cianflone F, Trevisani F, Dehò F, Briganti A, Salonia A, Montorsi F, Bertini R, Capitanio U.

World J Urol. 2018 Jul 25. doi: 10.1007/s00345-018-2412-6. [Epub ahead of print]

PMID:
30046844
8.

MicroRNAs as Mediators of Resistance Mechanisms to Small-Molecule Tyrosine Kinase Inhibitors in Solid Tumours.

Ghidini M, Hahne JC, Frizziero M, Tomasello G, Trevisani F, Lampis A, Passalacqua R, Valeri N.

Target Oncol. 2018 Aug;13(4):423-436. doi: 10.1007/s11523-018-0580-3.

PMID:
30006826
9.

Trans-arterial radioembolization for intermediate-advanced hepatocellular carcinoma: a budget impact analysis.

Rognoni C, Ciani O, Sommariva S, Bargellini I, Bhoori S, Cioni R, Facciorusso A, Golfieri R, Gramenzi A, Mazzaferro V, Mosconi C, Ponziani F, Sacco R, Trevisani F, Tarricone R.

BMC Cancer. 2018 Jul 5;18(1):715. doi: 10.1186/s12885-018-4636-7.

10.

Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: a proof of concept.

De Lorenzo S, Tovoli F, Barbera MA, Garuti F, Palloni A, Frega G, Garajovà I, Rizzo A, Trevisani F, Brandi G.

Sci Rep. 2018 Jul 3;8(1):9997. doi: 10.1038/s41598-018-28337-6.

11.

Correction: Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular Carcinoma.

Giannini EG, Moscatelli A, Pellegatta G, Vitale A, Farinati F, Ciccarese F, Piscaglia F, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Borzio F, Cabibbo G, Felder M, Sacco R, Morisco F, Missale G, Foschi FG, Gasbarrini A, Baroni GS, Virdone R, Masotto A, Trevisani F; and the Italian Liver Cancer (ITA.LI.CA) Group.

Am J Gastroenterol. 2018 Jul;113(7):1100. doi: 10.1038/s41395-018-0131-7.

PMID:
29910460
12.

Plasma cholesterol and lipoprotein levels in relation to tumor aggressiveness and survival in HCC patients.

Carr BI, Giannelli G, Guerra V, Giannini EG, Farinati F, Rapaccini GL, Marco MD, Zoli M, Caturelli E, Masotto A, Virdone R, Sacco R, Trevisani F.

Int J Biol Markers. 2018 Nov;33(4):423-431. doi: 10.1177/1724600818776838. Epub 2018 Jun 6.

PMID:
29874983
13.

Metabolic disorders across hepatocellular carcinoma in Italy.

Morisco F, Guarino M, Valvano MR, Auriemma F, Farinati F, Giannini EG, Ciccarese F, Tovoli F, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Borzio F, Sacco R, Cabibbo G, Felder M, Benvengù L, Gasbarrini A, Svegliati Baroni G, Foschi FG, Biasini E, Masotto A, Virdone R, Marra F, Caporaso N, Trevisani F; Italian Liver Cancer (ITA.LI.CA) group.

Liver Int. 2018 Nov;38(11):2028-2039. doi: 10.1111/liv.13877. Epub 2018 Jun 19.

PMID:
29745475
14.

The Effect of Anatomical Location of Lymph Node Metastases on Cancer Specific Survival in Patients with Clear Cell Renal Cell Carcinoma.

Nini A, Larcher A, Cianflone F, Trevisani F, Terrone C, Volpe A, Regis F, Briganti A, Salonia A, Montorsi F, Bertini R, Capitanio U.

Front Surg. 2018 Mar 28;5:26. doi: 10.3389/fsurg.2018.00026. eCollection 2018.

15.

[Personalized healthcare in hepatocellular carcinoma. Multi-society Italian position paper.]

Trevisani F, Garuti F, Neri A.

Recenti Prog Med. 2018 Jan;109(1):38-45. doi: 10.1701/2848.28753. Italian.

PMID:
29451521
16.

Physical exercise for late-life depression: Effects on symptom dimensions and time course.

Murri MB, Ekkekakis P, Menchetti M, Neviani F, Trevisani F, Tedeschi S, Latessa PM, Nerozzi E, Ermini G, Zocchi D, Squatrito S, Toni G, Cabassi A, Neri M, Zanetidou S, Amore M.

J Affect Disord. 2018 Apr 1;230:65-70. doi: 10.1016/j.jad.2018.01.004.

PMID:
29407540
17.

Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study Group.

Vitale A, Lai Q, Farinati F, Bucci L, Giannini EG, Napoli L, Ciccarese F, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Borzio F, Sacco R, Cabibbo G, Virdone R, Marra F, Felder M, Morisco F, Benvegnù L, Gasbarrini A, Svegliati-Baroni G, Foschi FG, Missale G, Masotto A, Nardone G, Colecchia A, Bernardi M, Trevisani F, Pawlik TM; Italian Liver Cancer (ITA.LI.CA) group.

J Gastrointest Surg. 2018 May;22(5):859-871. doi: 10.1007/s11605-018-3688-y. Epub 2018 Jan 19.

PMID:
29352441
18.

Response to Intermediate stage treatment: Is TACE enough?

Pecorelli A, Lenzi B, Trevisani F; Italian Liver Cancer (ITA.LI.CA) group.

Liver Int. 2018 Jan;38(1):188-189. doi: 10.1111/liv.13624. No abstract available.

PMID:
29272570
19.

Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation.

Trevisani F, Brandi G, Garuti F, Barbera MA, Tortora R, Casadei Gardini A, Granito A, Tovoli F, De Lorenzo S, Inghilesi AL, Foschi FG, Bernardi M, Marra F, Sacco R, Di Costanzo GG.

J Cancer Res Clin Oncol. 2018 Feb;144(2):403-414. doi: 10.1007/s00432-017-2556-6. Epub 2017 Dec 16.

PMID:
29249005
20.

Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice.

Giannini EG, Bucci L, Garuti F, Brunacci M, Lenzi B, Valente M, Caturelli E, Cabibbo G, Piscaglia F, Virdone R, Felder M, Ciccarese F, Foschi FG, Sacco R, Svegliati Baroni G, Farinati F, Rapaccini GL, Olivani A, Gasbarrini A, Di Marco M, Morisco F, Zoli M, Masotto A, Borzio F, Benvegnù L, Marra F, Colecchia A, Nardone G, Bernardi M, Trevisani F; Italian Liver Cancer (ITA.LI.CA) group.

Hepatology. 2018 May;67(5):1784-1796. doi: 10.1002/hep.29668. Epub 2018 Apr 6.

PMID:
29159910

Supplemental Content

Loading ...
Support Center